Healthcare & Life Sciences

Forcefield Therapeutics

series-a
series-a
Stage
1
Investors

About

Forcefield Therapeutics develops biologic therapeutics to protect heart function by preventing or arresting the loss of cardiomyocytes following myocardial infarction, aiming to reduce progression to heart failure.

Explore Forcefield Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.